Inflammatory gene polymorphisms and ischaemic heart disease: Review of population association studies

Heart

Volumn 87, Issue 2, 2002, Pages 107-112

  Andreotti, F ^a   Porto, I ^a   Crea, F ^a   Maseri, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; LYMPHOTOXIN; PADGEM PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

CELL ADHESION; CORONARY RISK; CYTOKINE PRODUCTION; DNA POLYMORPHISM; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; PATHOGENESIS; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW;

EID: 0036153485     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.87.2.107     Document Type: Review

References (52)

1. Atherosclerosis: An inflammatory disease
2. Genetics of inflammation and risk of coronary artery disease: The central role of interleukin-6
3. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
4. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity
5. Gene polymorphisms in the TNF locus and the risk of myocardial infarction
6. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The étude cas-temoin de l'infarctus du myocarde (ECTIM) study
7. Association of a T29->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese
8. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease
9. Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction
10. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factar for myocardial infarction
11. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men
12. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile
13. A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction
14. The P-selectin gene is highly polymorphic: Reduced frequency of the Pro715 carriers in patients with myocardial infarction
15. No evidence for the CD31 C/G gene polymorphism as an independent risk factor of coronary heart disease
16. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
17. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men
18. Tumour necrosis factor β alleles and hyperinsulinaemia in coronary artery disease
19. Transforming growth factor-beta 1 gene polymorphisms and coronary artery disease
20. A common polymorphism of the transforming growth factor β 1 gene and coronary artery disease
21. Association of genetic polymorphisms in the ACE, ApoE, and TGF beta genes with early onset ischemic heart disease
22. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting
23. E-selectin polymorphism and atherosclerosis: An association study
24. DNA polymorphisms in adhesion molecule genes: A new risk factor for early atherosclerosis
25. A Pstl polymorphism detects the mutation of serine128 to arginine in CD 62E gene: A risk factor for coronary artery disease
26. The homozygous combination of Leu125Val and Ser563Asn polymorphisms in the PECAM1 gene (CD31) is associated with early severe coronary heart disease
27. Tumour necrosis factor alpha and the cardiovascular system: Its role in cardiac allograft rejection and heart disease
28. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
29. Role of transforming growth factor beta in human disease
30. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions
31. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells
32. Interleukin 1 and interleukin 1 receptor antagonism
33. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1 beta production in vitro
34. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
35. Endotoxin: Possible roles in initiation and development of atherosclerosis
36. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14
37. Adhesion molecules in cell interaction
38. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions
39. Increased soluble form of P-selectin in patients with unstable angina
40. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells
41. Polymorphism of adhesion molecule CD 31 and its role in acute graft-versus-host disease
42. Soluble PECAM-1, but not P-selectin, nor osteonectin identify acute myocardial infarction in patients presenting with chest pain
43. Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of the adhesion receptors for leukocytes
44. Polymorphisms of the P-selectin gene and risk of myocardial infarctian in men and women in the ECTIM extension study
45. Functional characterization of atherosclerosis-associated Ser128Arg and Leu554Phe E-selectin mutations
46. The human PECAM1 gene maps to 17q23
47. Human molecular genetics
48. Association studies of genetic polymorphisms and complex diseases
49. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
50. Molecular genetics of coronary artery disease: Measuring the phenotype
51. Rapid, high fidelity analysis of simple sequence repeats on an electronically active DNA microchip
52. Microchip electrophoresis: A method for high-speed SNP detection